Parsing the risk of myocarditis from viral infection versus vaccination is challenging, and researchers are intensely studying the various factors that are at play.
Curbing vaccine hesitancy is as much a matter of acknowledging its social, historical, and cultural roots as it is of addressing its clinical dimensions.
Andrew Bubak, University of Colorado Anschutz Medical Campus; Diego Restrepo, University of Colorado Anschutz Medical Campus, and Maria Nagel, University of Colorado Anschutz Medical Campus
Inflammation and damage to the olfactory system from shingles, COVID-19 and herpes infections may contribute to Alzheimer’s disease.
A new study has looked at more than 15,000 people across 21 countries to assess whether vaccinated and unvaccinated people discriminate against each other.
Amphibians have been devastated by a chytrid fungus pandemic. Researchers immunized California red-legged frogs in Yosemite to give them a fighting chance at survival, with surprising results.
An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge for researchers.
Jaishree Raman, National Institute for Communicable Diseases
For a malaria vaccine to have an impact, health promotion is key. Awareness campaigns must address safety concerns and emphasise expected positive impacts.
Since immunity from COVID vaccination begins to wane over time, it’s important that everyone, irrespective of age, receives their boosters as soon as they are eligible to do so.
A major lesson from the COVID-19 pandemic is the need to decolonize transnational governance so that the world is better able to handle both future and current global crises.
Anna Howe, University of Auckland, Waipapa Taumata Rau; Emma Best, University of Auckland, Waipapa Taumata Rau, and Matthew Hobbs, University of Canterbury
The risk of serious disease outbreaks among NZ children is now very real. Some childhood immunisation rates have dropped from about 80% in early 2020 to 67% by June 2022, and as low as 45% for Māori.
There are two approved monkeypox vaccines in the US. Both use a related poxvirus called vaccinia to produce an immune response that protects against smallpox and monkeypox.
To control monkeypox, there is a short window — weeks, not months — in which to vaccinate the most susceptible and to encourage and support self-isolation for those who have symptoms.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand